Timothy Walbert

Chairman, President & CEO, Horizon Therapeutics
Relationships Interlocks Giving Data

Board Memberships

Exicure Inc Clinical-stage gene regulatory and immuno-oncology therapeutics biotechnology company. Revenues are $1 billion.
• Board Member ('20→?)

Positions

Horizon Pharma PLC
• Chairman, President, and CEO

Federal Election Campaign Contributions

Orrin Hatch Late Former US Senator from Utah (1977-2019)
• 5 contributions · 7,700 USD (Mar 22 '17→Feb 26 '18)
Brady Victory Fund
• 1 contribution · 5,000 USD (Oct 5 '16)
Greg Walden Republican US Representative from Oregon (R-02)
• 2 contributions · 5,000 USD (Mar 31 '17)
Roy Blunt US Senator from Missouri (2011-present); former US Representative 1997-2011
• 2 contributions · 5,000 USD (Jul 18 '16)
Ron Wyden Democratic US Senator and Former Representative from Oregon
• 1 contribution · 2,700 USD (Jul 14 '16)
Biotechnology Industry Organization Biotech industry association
• 6 contributions · 2,250 USD (Mar 15 '16→Jun 18 '18)
Brad Schneider US Representative from Illinois (2013-2015 and 2017-present)
• 1 contribution · 1,000 USD (May 27 '14)
New Pioneers PAC
• 1 contribution · 1,000 USD (Jul 17 '17)
Peter Roskam Former US Representative R-Illinois
• 1 contribution · 1,000 USD (Jun 18 '18)
Robert Dold US Representative from Illinois
• 2 contributions · 500 USD (Oct 6 '15)
Timothy Walbert
Updated over 4 years ago

Basic Info

Types Person, Business Person
Gender Male

Source Links

22 documents :: see all